Carcinogenesis Advance Access published online on January 30, 2004
Carcinogenesis, doi:10.1093/carcin/bgh079
© 2004 by Oxford University Press
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
CANCER BIOLOGY
1 Molecular Nutrition Unit, Department of Food and Nutrition, Technical University of Munich, Hochfeldweg 2, D-85350 Freising, FRG
* Corresponding author. E-mail: uwenzel{at}wzw.tum.de.
Received 6 October 2003
; revised 19 December 2003
; accepted 6 January 2004
Although a high alimentary intake of antioxidant vitamins such as ascorbic acid may play an important role in cancer prevention, a high level of antioxidants may have quite different effects at different stages of the transformation process. In cancer development, the resistance of cells to apoptosis is one of the most crucial steps. We have tested the effects of acorbic acid on apoptosis in HT-29 human colon carcinoma cells when induced by two potent apoptosis inducers, the classical anti-tumor drug camptothecin or the flavonoid flavone. Apoptosis was assessed based on caspase-3-like activity, plasma membrane disintegration and finally nuclear fragmentation and chromatin condensation. Ascorbic acid dose-dependently inhibited the apoptotic response of cells to camptothecin and flavone. RT-PCR analysis and Western-blot analysis revealed that ascorbic acid specifically blocked the decrease of bcl-XL by camptothecin or flavone. An increased generation of mitochondrial O2-. precedes the down-regulation of bcl-XL by camptothecin and flavone and ascorbic acid at a concentration of 1 mM prevented the generation of this reactive oxygen species. In conclusion, ascorbic acid functions as a potent antioxidant in mitochondria of human colon cancer cells and thereby blocks drug-mediated apoptosis induction allowing cancer cells to become insensitive to chemotherapeutics.
Ascorbic acid suppresses drug-induced apoptosis in human colon cancer cells by scavenging mitochondrial superoxide anions
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  I. Winkelmann, D. Diehl, D. Oesterle, H. Daniel, and U. Wenzel The suppression of aberrant crypt multiplicity in colonic tissue of 1,2-dimethylhydrazine-treated C57BL/6J mice by dietary flavone is associated with an increased expression of Krebs cycle enzymes Carcinogenesis, July 1, 2007; 28(7): 1446 - 1454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. E. Juan, U. Wenzel, V. Ruiz-Gutierrez, H. Daniel, and J. M. Planas Olive Fruit Extracts Inhibit Proliferation and Induce Apoptosis in HT-29 Human Colon Cancer Cells J. Nutr., October 1, 2006; 136(10): 2553 - 2557. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Y. Liu, G. L. Borchert, S. P. Donald, A. Surazynski, C.-A. Hu, C. J. Weydert, L. W. Oberley, and J. M. Phang MnSOD inhibits proline oxidase-induced apoptosis in colorectal cancer cells Carcinogenesis, August 1, 2005; 26(8): 1335 - 1342. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
U. Wenzel, A. Nickel, and H. Daniel Increased Carnitine-Dependent Fatty Acid Uptake into Mitochondria of Human Colon Cancer Cells Induces Apoptosis J. Nutr., June 1, 2005; 135(6): 1510 - 1514. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. C. Stern, K. D. Siegmund, R. Corral, and R. W. Haile XRCC1 and XRCC3 Polymorphisms and Their Role as Effect Modifiers of Unsaturated Fatty Acids and Antioxidant Intake on Colorectal Adenomas Risk Cancer Epidemiol. Biomarkers Prev., March 1, 2005; 14(3): 609 - 615. [Abstract] [Full Text] [PDF]
|
|